Russian Pharmaceutical Forum

24 - 25 November 2020

Agenda Speakers Brochure

Elena Kartasheva

President

Takeda

Matthias Wernicke

Managing Director, Russia and CIS

Merck

Ugur Gunaydin

General Director, Russia & CIS

Amgen

Irina Zaporozhets

General Manager, Russia & CIS

Eli Lilly & Company

Inna Bakumenko

General Manager Russia and CIS

Abbott

Marek Vasicek

General Manager, Russia

Bristol Myers Squibb

Stephan Eder

Executive Vice President, Russia and CIS

STADA

Elena Litvinova

General Director

NovaMedica

Peter Rodionov

General Manager

Geropharm

Maxim Stetsyuk

Executive Director, member of the Management Board

Nanolek

Adlane Soudani

General Manager

Ipsen

Vasily Ignatiev

General Director

R-Pharm

Frederic Jumel

General Manager

Sanofi Pasteur

Ivan Poljak

General Manager

Abbott’s Veropharm

Anastasia Karpova

General Director

Erkafarm

Valentina Buchneva

Head of Region Eurasia

Bosnalijek

Alexander Filippov

General Director

Rigla

Dmitry Pogrebinsky

General Director

Protek

Alexander Kuzin

General Director

Pharmacy Chain 36.6

Evgeniy Nifantyev

General Director

Retail Chain “Neopharm”

Alexander Bykov

Director of Healthcare Economics

R-Pharm

Yury Krestinskiy

Chairman of the Expert Board

Institute of Public Healthcare Development

Alexandr Sokolov

Key Account Director

Teva

Elena Nevolina

Executive Director

National Pharmaceutical Chamber

Lilia Titova

Executive Director

The Union of Professional Pharmaceutical Organizations (SPFO)

Igor Bakhmetiev

Commercial Director, Russia and CIS

STADA

Ilya Afanasov

Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health

Bayer

David Pérez Godia

Supply Chain Manager, Russia & CIS

Merck

Oxana Kudelya

Market Access, Pricing and Commercial Director, Russia & CIS

Merck

Anastasia Tatarnikova

Chairman

Home for Rares

Alisa Dzhangiryants

Director, MA & Pricing Department

Bristol Myers Squibb

Larisa Popovich

Director, Institute for Health Economics

Higher School of Economics

Vitaly Dembrovskiy

Market Access Director, Russia and Eurasia

AstraZeneca

Vilena Galkina

Government Affairs Director

Geropharm

Marina Rykova

Marketing Director

Geropharm

Rustam Iksanov

Vice President, R&D

NovaMedica

Yuriy Mochalin

Director of Corporate Communications, Eurasia

Sanofi

Andrey Kolesnikov

Senior Director Government Affairs & Market Access, Russia and Eurasia

Teva

Anna Konstantinova

Digital Client Partner

Pfizer

Alexey Migulin

Market Access Director, Russia and Belarus

Pfizer

Artyom Selyanskiy

Head of Track & Trace, Russia and CIS

STADA

Maria Lituchaya

General Manager, Russia & CIS

CSL Behring

Alexander Evstashenkov

Head of Expert Consulting Centre

Institute of Public Procurement

Viktor Trukhin

Director

St. Petersburg Research Institute of Vaccines and Serums of the FMBA of Russia

Irina Romanova

Head of Consumer Healthcare in Eurasia zone

Sanofi

Anastasia Altaychinova

National Sales Manager, Consumer Healthcare

Sanofi

Kirill Danishevskiy

Market Access Director

Takeda

Natalia Lazareva

MD, Professor, Clinical pharmacology department

Sechenov University

Dmitry Vlasov

Medical Director Russia, Head Medical Cluster CIS

Bayer

Alexei Shavenzov

GA&P Senior Director Russia & CIS

Johnson & Johnson

Jurate Svarcaite

Director General

Association of the European Self-Care Industry (AESGP)

Alexander Rudko

General Director

R&D-centre NovaMedica Innotech

Svyatoslav Plavinsky

Professor

North-western State Medical University named after I.I. Mechnikov

Yuriy Zhulev

President

Russian Hemophilia Society

Evgeniy Gordeev

Managing partner

Breffi

Herman Inozemtsev

General Manager

PharmaSpace

Vladimir Egorov

General Manager

Proxima Research Russia

Angela Simakova

Trade & Revenue Director

Sanofi in Eurasian region

Valery Eremenko

Partner, Head of Litigation Practice

Egorov Puginsky Afanasiev & Partners Law firm

Zakhar Golant

Head of Board

The Union of Pharmaceutical and Biomedical Clusters

Anna Ermolaeva

General Director

AlphaRM

Andrey Zelenin

Managing Partner

Lidings

Olga Pentegova

Deputy General Director for Legal Affairs

Association of Russian Pharmaceutical Manufacturers

The Russian Pharmaceutical Forum goes VIRTUAL in 2020

Join us at the Russian Pharmaceutical Forum – a unique online gathering of key industry experts in the pharmaceutical sector!
In order to manage and comply with travel and social distancing restrictions, the Russian Pharmaceutical Forum will be hosted virtually on a FULLY INTERACTIVE ONLINE PLATFORM.

Stream sessions with leading pharma representatives and ask your questions to speakers in real time!

Meet new partners and digitally connect with key market players – via online chat, email and video calls!

Join the event directly from your laptop, tablet or smartphone – and save on time, money and travel!

Key topics at the Russian Pharmaceutical Forum 2020:

Analysis of the key regulatory changes affecting the pharmaceutical industry
COVID-19 pandemic: the response of the Russian pharmaceutical market
Drug pricing methodologies aimed at stimulating innovation
Drug labelling - success stories and implementation case studies
Public procurement optimisation and the formation of the Essential and Vital Drug List
How to ensure access to innovative treatments on the Russian market?
Evolution in producer - distributor - retailer dynamics
Sales trends, purchasing power and consumer demand forecasts
Developing the local active pharmaceutical substance production market
Medicine of the future: genomics, biotechnologies, personalised medicine

Digitalisation of the pharmaceutical industry and the healthcare system

Digital healthcare: telemedicine today and in the future
IT trends: best practices in using mobile technologies in the pharmaceutical industry
Data-centric marketing and data analytics for strategic planning
Smart technologies and innovation in drug manufacturing
New business models and online retail: consumer market transformation
Analytics, opportunities to share best practice and success stories from top pharma leaders

Pharma versus coronavirus: interviews with General Directors

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19.

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products.

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation.

READ OUR PHRAMACEUTICAL BLOG>>

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA